Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis.

Diagnostics of progression of liver fibrosis in patients with non-alcoholic steatohepatitis combined with obesity and chronic calculous cholecystitis.

The aim of the work is to investigate the diagnostic value of laboratory blood biomarkers – alanine aminotransferase, aspartate aminotransferase, oxyproline and prothrombin time in comparison with morphological indicators for diagnosis of the degree of liver fibrosis in patients with comorbid course...

Full description

Bibliographic Details
Main Author:	A. Yu. Filippova
Format:	Article
Language:	English
Published:	SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine" 2020-04-01
Series:	Medičnì Perspektivi
Subjects:	nonalcoholic steatohepatitis obesity fibrosis histological diagnostics
Online Access:	http://journals.uran.ua/index.php/2307-0404/article/view/200403

Similar Items

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
by: D.N. Amarapurkar, et al.
Published: (2006-01-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
by: A. Yu. Filippova
Published: (2017-04-01)

Research advances in noninvasive diagnostic methods for nonalcoholic steatohepatitis
by: HU Mengqi
Published: (2017-12-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
by: Rui Yu, et al.
Published: (2018-04-01)

Possibilities of correction of lipid-phospholipid disorders in patients with non-alcoholic steatohepatitis against obesity and pathology of the biliary tract.
by: A. Yu. Filippova
Published: (2019-11-01)

Prediction of course and progression of nonalcoholic fatty liver disease in patients with obesity and pathology of the biliary tract with the help of mathematical modeling.
by: A. Yu. Filippova, et al.
Published: (2017-12-01)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
by: Nahum Mendez-Sanchez, et al.
Published: (2018-07-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice
by: Xue-Jing Liu, et al.
Published: (2020-06-01)

Morphological basis for the assessment of steatosis, steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease associated with obesity and pathology of the biliary tract
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats
by: Lulu Wang, et al.
Published: (2017-08-01)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
by: Maria Del Ben, et al.
Published: (2018-02-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

CHOP deficiency attenuates steatohepatitis, fibrosis and carcinogenesis in mice fed an MCD diet
by: Toriguchi, Kan
Published: (2014)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
by: Hannah K. Drescher, et al.
Published: (2019-08-01)

Can FIB4 and NAFLD fibrosis scores help endocrinologists refer patients with non-alcoholic fat liver disease to a hepatologist?
by: Rodrigo Bremer Nones, et al.
Published: (2017-02-01)

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease
by: Georgios Kranidiotis, et al.
Published: (2013-05-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: ZHU Peng
Published: (2014-09-01)

Histological Remission during Corticosteroid Therapy of Overlapping Nonalcoholic Steatohepatitis and Autoimmune Hepatitis: Case Report and Literature Review
by: Shinichiroh Fukuda, et al.
Published: (2011-09-01)

Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients
by: Haghpanah Babak, et al.
Published: (2003-10-01)

Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress
by: Sarayu A. Pai, et al.
Published: (2019-03-01)

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis
by: Teresa Auguet, et al.
Published: (2020-06-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease
by: Marek Waluga, et al.
Published: (2017-09-01)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Ji-Young Cha, et al.
Published: (2018-12-01)

Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis
by: Stergios A. Polyzos, et al.
Published: (2020-09-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
by: F. N. Ramalho, et al.
Published: (2017-10-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
by: Jin Ha Lee, et al.
Published: (2020-10-01)

Influence of platelet-enriched plasma on the morpho-functional state of liver in rats with induced non-alcoholic steatohepatitis and dyslipidemia
by: O. Appelhans, et al.
Published: (2020-06-01)

Features of the connective tissue metabolism, the content of adipokines and cytokeratin-18 in patients with non-alcoholic steatohepatitis combined with osteoarthritis and obesity
by: O. S. Khukhlina, et al.
Published: (2019-07-01)

A Young Adult Patient with Nonalcoholic Steatohepatitis Developed Severe Gastroesophageal Varices Associated with Severe Obesity and Diabetes Mellitus
by: Yuichi Honma, et al.
Published: (2018-08-01)

Green tea extract protects against diethylnitrosamine-mediated liver injury and cell proliferation by attenuating STAT3 and iNOS expression in high fat-induced obese mice with nonalcoholic steatohepatitis
by: Kim, Joshua B.
Published: (2017)

Caspase-11–Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic SteatohepatitisSummary
by: Yingwei Zhu, et al.
Published: (2021-01-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)